½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1525259

¼¼°èÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, Áö¿ªº° ¿¹Ãø(2024-2032³â)

Global Peripheral Vascular Devices Market Size study, by Type and Regional Forecasts 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® 285 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀº 2023³â 97¾ï 5,780¸¸ ´Þ·¯·Î Ãß»êµÇ¸ç, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.1% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸»ÃÊÇ÷°ü ±â±â´Â ½ÉÀå ÀÌ¿ÜÀÇ Ç÷¾×¼øȯ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸»ÃÊÇ÷°üÁúȯ(PVD)ÀÇ Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº Ç÷°üÀÇ °æ·Ã, ¸·Èû, ÇùÂøÀ» À¯¹ßÇϸç, ƯÈ÷ ´Ù¸®¿Í ³ú¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â Á¤¸Æ°ú ¸²ÇÁ°ü¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÌ·¯ÇÑ ½Åü ºÎÀ§°¡ È¿°úÀûÀ¸·Î ±â´ÉÇϱâ À§Çؼ­´Â ÀûÀýÇÑ Ç÷·ù¿¡ ÀÇÁ¸Çϱ⠶§¹®¿¡ PVD´Â ƯÈ÷ °¡Àå ÀϹÝÀûÀ¸·Î ¿µÇâÀ» ¹Þ±â ½¬¿î ´Ù¸®¿Í Ç㸮ÀÇ °Ç°­¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

Àα¸ °í·ÉÈ­, ÁÂ½Ä »ýÈ°½À°ü, ´ç´¢º´ ¹× Èí¿¬À² Áõ°¡´Â PVDÀÇ ÁÖ¿ä ÇÏÀ§ ÁýÇÕÀÎ ¸»Ãʵ¿¸ÆÁúȯ(PAD)ÀÇ ¹ß»ý·ü Áõ°¡¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. PAD¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Áø´Ü ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó Áúº´ÀÇ Á¶±â ¹ß°ßÀÌ Çâ»óµÇ¾î ÀÇ·áÀû °³ÀÔÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀο¡µµ ºÒ±¸ÇÏ°í, ½ÃÀåÀº È¿°úÀûÀÎ ´ëü Ä¡·á¹ý, ƯÈ÷ ³ôÀº È¿´É°ú ³»¾à¼ºÀ¸·Î ÀÎÇØ ³Î¸® »ç¿ëµÇ°í ÀÖ´Â ´Ùºñ°¡Æ®¶õ°ú °°Àº Ç×ÀÀ°íÁ¦ÀÇ µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Ç÷°ü È®ÀåÁ¦, ÄÝ·¹½ºÅ×·Ñ ÀúÇÏÁ¦, Ç×Ç÷¼ÒÆÇÁ¦ µî ´Ù¸¥ ¾à¹°µéµµ PAD Ä¡·áÀÇ ´ë¾ÈÀ¸·Î ÀÛ¿ëÇÏ¿© ¸»ÃÊÇ÷°ü ±â±âÀÇ È®Àå¿¡ Å« Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ, ÀÇ·á ±â°ü ¹× ȯÀÚµéÀº ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ°í ȸº¹ ±â°£À» ´ÜÃàÇÏ´Â »õ·Î¿î ±â¼úÀ» äÅÃÇÏ°í ÀÖ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ°í ÀÖÀ¸¸ç, PAD´Â ³ë³âÃþ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇϸç, Àü ¼¼°èÀûÀ¸·Î °í·ÉÈ­·Î ÀÎÇØ Ç÷°ü ÁßÀç¼úÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¾î ¸»ÃÊÇ÷°ü ±â±âÀÇ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, ±âŸ Áö¿ªÀÔ´Ï´Ù. 2023³â ºÏ¹Ì°¡ 39.5%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀ» ÁÖµµÇßÀ¸¸ç, ½ÉÇ÷°ü Áúȯ ¹ßº´·ü Áõ°¡, °í·É Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¾÷°è ±â¾÷ÀÇ Á¸Àç¿Í Á¦ÈÞ, ÇÕº´, ÆÄÆ®³Ê½Ê, ½ÅÁ¦Ç° Ãâ½Ã¿Í °°Àº Àü·«Àû À̴ϼÅƼºê°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. À¯·´Àº Àα¸ °í·ÉÈ­¿Í Ç÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇØ ÃÖ¼Òħ½ÀÀû Ç÷°ü ÁßÀç¼ú ÀåºñÀÇ °³¹ßÀ» ÃËÁøÇÏ´Â ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå : ÁÖ¿ä ¿ä¾à

  • ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2024-2030³â)
  • Áö¿ªº° °³¿ä
  • ºÎ¹®º° °³¿ä
    • À¯Çüº°
  • ÁÖ¿ä µ¿Çâ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦2Àå ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå Á¤ÀÇ¿Í Á¶»ç °¡Á¤

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ
  • Á¶»ç °¡Á¤
    • Æ÷ÇÔ°ú Á¦¿Ü
    • Á¦ÇÑ»çÇ×
    • °ø±ÞÃø ºÐ¼®
      • ÀÔ¼ö °¡´É¼º
      • ÀÎÇÁ¶ó
      • ±ÔÁ¦ ȯ°æ
      • ½ÃÀå °æÀï
      • °æÁ¦¼º(¼ÒºñÀÚÀÇ °üÁ¡)
    • ¼ö¿äÃø ºÐ¼®
      • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
      • ±â¼úÀÇ Áøº¸
      • ģȯ°æ
      • ¼ÒºñÀÚ Àǽİú ¼ö¿ë
  • Á¶»ç ¹æ¹ý
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸»Ãʵ¿¸ÆÁúȯ(PAD) ¹ß»ý·ü »ó½Â
    • °í·ÉÀÚ Àα¸ Áõ°¡
    • Áø´Ü ¸ð´Þ¸®Æ¼¿¡ ´ëÇÑ ÀÎ½Ä È®»ê°ú Áøº¸
  • ½ÃÀå °úÁ¦
    • ´ëü Ä¡·áÀÇ Á¸Àç
    • ±ÔÁ¦»ó °úÁ¦
  • ½ÃÀå ±âȸ
    • ±â¼ú Çõ½Å°ú ¿¬±¸°³¹ß ÅõÀÚ
    • ½ÅÈï ½ÃÀå ¼ºÀå

Á¦4Àå ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå : »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
    • Porter's 5 Force ¿µÇ⠺м®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • Æı«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Çüº°, 2024-2030³â

  • ºÎ¹® ´ë½Ãº¸µå
  • ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå : À¯Çüº° ¸ÅÃâ µ¿Ç⠺м®, 2022³â¡¤2030³â
    • ¸»ÃÊ ½ºÅÙÆ®
    • PTA dz¼±
    • Ä«Å×ÅÍ
    • º¹ºÎ ´ëµ¿¸Æ ½ºÅÙÆ® ±×·¡ÇÁÆ® ³»»ð¼ú
    • ÇöóÅ© º¯Çü ±â±â
    • ¸»ÃÊ ¾×¼¼¼­¸®
    • ÇÏ´ëÁ¤¸Æ ÇÊÅÍ
    • Ç÷¿ªÇÐ °³¼± ±â±â

Á¦6Àå ¸»ÃÊÇ÷°ü ±â±â ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2024-2030³â

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦7Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Abbott Laboratories
    • Angioscore Inc.
    • Edward Lifesciences Corporation
    • Medtronic Inc.
    • St. Jude Medical
    • Teleflex Medical
    • Volcano Corporation
    • Boston Scientific Corporation
    • Teleflex Medical
    • Cook Group Inc.

Á¦8Àå Á¶»ç °úÁ¤

ksm 24.08.20

The global Peripheral Vascular Devices Market was estimated at USD 9,757.8 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2032. Peripheral vascular devices are critical in the treatment of peripheral vascular diseases (PVDs), which affect blood circulation outside the heart. These conditions can lead to spasms, blockages, or narrowing of the blood vessels, affecting veins and lymphatic vessels, particularly those supplying blood to the legs and brain. As these body parts rely on proper blood flow to function effectively, PVDs can significantly impact health, particularly in the legs and feet, which are most commonly affected.

The aging population, sedentary lifestyles, and the rising prevalence of diabetes and smoking contribute to the growing incidence of Peripheral Artery Disease (PAD), a major subset of PVD. This surge in PAD cases drives the demand for peripheral vascular devices used in both diagnostic and therapeutic interventions. Increased awareness about PAD and advancements in diagnostic techniques have improved early disease detection, thereby increasing the number of patients requiring medical interventions and driving market growth. Despite these growth drivers, the market faces challenges from highly effective alternative treatments, particularly anticoagulant drugs like Dabigatran, which are widely used due to their high efficacy and tolerability. Other medications, such as vasodilators, cholesterol-lowering drugs, and antiplatelet medicines, also serve as alternatives to PAD treatment, posing a significant hurdle to the expansion of peripheral vascular devices. Also, governments, healthcare entities, and patients are increasingly adopting novel technologies that offer enhanced clinical outcomes and quicker recovery periods, further boosting market growth. As PAD is more prevalent among the elderly, the rising aging population globally is expected to increase the number of patients requiring vascular interventions, thereby fostering demand for peripheral vascular devices.

The key regions considered for the Global Peripheral Vascular Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the peripheral vascular devices market with a revenue share of 39.5%, driven by factors such as the increasing incidence of cardiovascular diseases and a growing geriatric population. The presence of major industry players and their strategic initiatives, including collaborations, mergers, partnerships, and novel product launches, further boost market growth. Europe is anticipated to grow at the fastest CAGR during the forecast period, due to its aging population and rising prevalence of vascular diseases, coupled with continuous advancements in medical technology fostering the development of minimally invasive vascular intervention devices.

Major market players included in this report are:

  • Abbott Laboratories
  • Angioscore Inc.
  • Edward Lifesciences Corporation
  • Medtronic Inc.
  • St. Jude Medical
  • Teleflex Medical
  • Volcano Corporation
  • Boston Scientific Corporation
  • Teleflex Medical
  • Cook Group Inc.

The detailed segments and sub-segment of the market are explained below:

By Type:

  • Peripheral Stents
  • PTA Balloons
  • Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Plaque Modification Devices
  • Peripheral Accessories
  • Inferior Vena Cava Filters
  • Hemodynamic Flow Alteration Devices

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2030

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2024 to 2030.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Peripheral Vascular Devices Market Executive Summary

  • 1.1. Global Peripheral Vascular Devices Market Size & Forecast (2024-2030)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
  • 1.4. Key Trends
  • 1.5. Analyst Recommendations & Conclusion

Chapter 2. Global Peripheral Vascular Devices Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Peripheral Vascular Devices Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Incidence of Peripheral Artery Disease (PAD)
    • 3.1.2. Growing Geriatric Population
    • 3.1.3. Increasing Awareness and Advancements in Diagnostic Modalities
  • 3.2. Market Challenges
    • 3.2.1. Presence of Alternative Treatment Options
    • 3.2.2. Regulatory Challenges
  • 3.3. Market Opportunities
    • 3.3.1. Technological Innovations and R&D Investments
    • 3.3.2. Growth in Emerging Markets

Chapter 4. Global Peripheral Vascular Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunities
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Peripheral Vascular Devices Market Size & Forecasts by Type 2024-2030

  • 5.1. Segment Dashboard
  • 5.2. Global Peripheral Vascular Devices Market: Type Revenue Trend Analysis, 2022 & 2030 (USD Million)
    • 5.2.1. Peripheral Stents
    • 5.2.2. PTA Balloons
    • 5.2.3. Catheters
    • 5.2.4. Endovascular Aneurysm Repair Stent Grafts
    • 5.2.5. Plaque Modification Devices
    • 5.2.6. Peripheral Accessories
    • 5.2.7. Inferior Vena Cava Filters
    • 5.2.8. Hemodynamic Flow Alteration Devices

Chapter 6. Global Peripheral Vascular Devices Market Size & Forecasts by Region 2024-2030

  • 6.1. North America Peripheral Vascular Devices Market
    • 6.1.1. U.S. Peripheral Vascular Devices Market
      • 6.1.1.1. Type breakdown size & forecasts, 2024-2030
    • 6.1.2. Canada Peripheral Vascular Devices Market
  • 6.2. Europe Peripheral Vascular Devices Market
    • 6.2.1. UK Peripheral Vascular Devices Market
    • 6.2.2. Germany Peripheral Vascular Devices Market
    • 6.2.3. France Peripheral Vascular Devices Market
    • 6.2.4. Spain Peripheral Vascular Devices Market
    • 6.2.5. Italy Peripheral Vascular Devices Market
    • 6.2.6. Rest of Europe Peripheral Vascular Devices Market
  • 6.3. Asia-Pacific Peripheral Vascular Devices Market
    • 6.3.1. China Peripheral Vascular Devices Market
    • 6.3.2. India Peripheral Vascular Devices Market
    • 6.3.3. Japan Peripheral Vascular Devices Market
    • 6.3.4. Australia Peripheral Vascular Devices Market
    • 6.3.5. South Korea Peripheral Vascular Devices Market
    • 6.3.6. Rest of Asia Pacific Peripheral Vascular Devices Market
  • 6.4. Latin America Peripheral Vascular Devices Market
    • 6.4.1. Brazil Peripheral Vascular Devices Market
    • 6.4.2. Mexico Peripheral Vascular Devices Market
    • 6.4.3. Rest of Latin America Peripheral Vascular Devices Market
  • 6.5. Middle East & Africa Peripheral Vascular Devices Market
    • 6.5.1. Saudi Arabia Peripheral Vascular Devices Market
    • 6.5.2. South Africa Peripheral Vascular Devices Market
    • 6.5.3. Rest of Middle East & Africa Peripheral Vascular Devices Market

Chapter 7. Competitive Intelligence

  • 7.1. Key Company SWOT Analysis
  • 7.2. Top Market Strategies
  • 7.3. Company Profiles
    • 7.3.1. Abbott Laboratories
    • 7.3.2. Angioscore Inc.
    • 7.3.3. Edward Lifesciences Corporation
    • 7.3.4. Medtronic Inc.
    • 7.3.5. St. Jude Medical
    • 7.3.6. Teleflex Medical
    • 7.3.7. Volcano Corporation
    • 7.3.8. Boston Scientific Corporation
    • 7.3.9. Teleflex Medical
    • 7.3.10. Cook Group Inc.

Chapter 8. Research Process

  • 8.1. Research Process
    • 8.1.1. Data Mining
    • 8.1.2. Analysis
    • 8.1.3. Market Estimation
    • 8.1.4. Validation
    • 8.1.5. Publishing
  • 8.2. Research Attributes
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦